Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatem A Azim

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|August 19, 2014
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete responseEvandro de Azambuja, Andrew P Holmes, Martine Piccart-Gebhart, et al.
Journal of the National Cancer Institute|December 7, 2023
Taxanes for the treatment of breast cancer during pregnancy: an international cohort studyAna S Ferrigno Guajardo, Bryan F Vaca-Cartagena, Erica L Mayer, et al.
JCO Global Oncology|January 13, 2022
Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast CancerShah Zeb Khan, Luca Arecco, Cynthia Villarreal-Garza, et al.
Nature Communications|December 11, 2020
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cellsClara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2018
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient DataDimitrios Zardavas, Luc Te Marvelde, Roger L Milne, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> MutationsMatteo Lambertini, Lieveke Ameye, Anne-Sophie Hamy, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|September 23, 2025
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]Isabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|August 19, 2014
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete responseEvandro de Azambuja, Andrew P Holmes, Martine Piccart-Gebhart, et al.
Journal of the National Cancer Institute|December 7, 2023
Taxanes for the treatment of breast cancer during pregnancy: an international cohort studyAna S Ferrigno Guajardo, Bryan F Vaca-Cartagena, Erica L Mayer, et al.
JCO Global Oncology|January 13, 2022
Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast CancerShah Zeb Khan, Luca Arecco, Cynthia Villarreal-Garza, et al.
Nature Communications|December 11, 2020
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cellsClara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2018
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient DataDimitrios Zardavas, Luc Te Marvelde, Roger L Milne, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> MutationsMatteo Lambertini, Lieveke Ameye, Anne-Sophie Hamy, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|September 23, 2025
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]Isabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Pageof 14